Allogene Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Allogene Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2017 to Q4 2023.
  • Allogene Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $18.9M, a 29.7% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $18.9M +$4.33M +29.7% Dec 31, 2023 10-K 2024-03-14
Q4 2022 $14.6M +$4.77M +48.7% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $9.8M +$3.64M +59% Dec 31, 2021 10-K 2024-03-14
Q4 2020 $6.16M +$3.01M +95.7% Dec 31, 2020 10-K 2024-03-14
Q4 2019 $3.15M +$2.23M +242% Dec 31, 2019 10-K/A 2024-03-14
Q4 2018 $920K +$920K Dec 31, 2018 10-K 2022-02-23
Q4 2017 $0 Dec 31, 2017 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.